BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27660269)

  • 1. ER Stress Induced by Tunicamycin Triggers α-Synuclein Oligomerization, Dopaminergic Neurons Death and Locomotor Impairment: a New Model of Parkinson's Disease.
    Cóppola-Segovia V; Cavarsan C; Maia FG; Ferraz AC; Nakao LS; Lima MM; Zanata SM
    Mol Neurobiol; 2017 Oct; 54(8):5798-5806. PubMed ID: 27660269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.
    Subbarayan MS; Hudson C; Moss LD; Nash KR; Bickford PC
    J Neuroinflammation; 2020 Aug; 17(1):242. PubMed ID: 32799878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.
    Boi L; Pisanu A; Palmas MF; Fusco G; Carboni E; Casu MA; Satta V; Scherma M; Janda E; Mocci I; Mulas G; Ena A; Spiga S; Fadda P; De Simone A; Carta AR
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DA-9805 protects dopaminergic neurons from endoplasmic reticulum stress and inflammation.
    Kang S; Piao Y; Kang YC; Lim S; Pak YK
    Biomed Pharmacother; 2022 Jan; 145():112389. PubMed ID: 34775235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activating transcription factor-4 promotes neuronal death induced by Parkinson's disease neurotoxins and α-synuclein aggregates.
    Demmings MD; Tennyson EC; Petroff GN; Tarnowski-Garner HE; Cregan SP
    Cell Death Differ; 2021 May; 28(5):1627-1643. PubMed ID: 33277577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson's disease.
    Milanese C; Cerri S; Ulusoy A; Gornati SV; Plat A; Gabriels S; Blandini F; Di Monte DA; Hoeijmakers JH; Mastroberardino PG
    Cell Death Dis; 2018 Jul; 9(8):818. PubMed ID: 30050065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Effects of Selenium on Alpha-Synuclein Accumulation in Substantia Nigra Pars Compacta in a Rat Model of Parkinson's Disease: Behavioral and Biochemical Outcomes.
    Salaramoli S; Joshaghani HR; Hosseini M; Hashemy SI
    Biol Trace Elem Res; 2024 Mar; 202(3):1115-1125. PubMed ID: 37386228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity.
    Olsen AL; Feany MB
    Neurobiol Dis; 2021 Nov; 159():105482. PubMed ID: 34390834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis in Parkinson's disease: Molecular mechanisms and therapeutic potential.
    Ding XS; Gao L; Han Z; Eleuteri S; Shi W; Shen Y; Song ZY; Su M; Yang Q; Qu Y; Simon DK; Wang XL; Wang B
    Ageing Res Rev; 2023 Nov; 91():102077. PubMed ID: 37742785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein pathology is associated with astrocyte senescence in a midbrain organoid model of familial Parkinson's disease.
    Muwanigwa MN; Modamio-Chamarro J; Antony PMA; Gomez-Giro G; Krüger R; Bolognin S; Schwamborn JC
    Mol Cell Neurosci; 2024 Mar; 128():103919. PubMed ID: 38307302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via cardiolipin externalization.
    Lurette O; Martín-Jiménez R; Khan M; Sheta R; Jean S; Schofield M; Teixeira M; Rodriguez-Aller R; Perron I; Oueslati A; Hebert-Chatelain E
    Cell Death Dis; 2023 Nov; 14(11):729. PubMed ID: 37949858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies targeting endoplasmic reticulum stress to improve Parkinson's disease.
    Wang D; Qu S; Zhang Z; Tan L; Chen X; Zhong HJ; Chong CM
    Front Pharmacol; 2023; 14():1288894. PubMed ID: 38026955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration.
    Acosta G; Race N; Herr S; Fernandez J; Tang J; Rogers E; Shi R
    Mol Cell Neurosci; 2019 Jul; 98():140-154. PubMed ID: 31201929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal Changes in Parkinson's Disease: A Non-invasive Biomarker for Early Diagnosis.
    Subramaniam MD; Aishwarya Janaki P; Abishek Kumar B; Gopalarethinam J; Nair AP; Mahalaxmi I; Vellingiri B
    Cell Mol Neurobiol; 2023 Nov; 43(8):3983-3996. PubMed ID: 37831228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy and UPS pathway contribute to nicotine-induced protection effect in Parkinson's disease.
    Ullah I; Uddin S; Zhao L; Wang X; Li H
    Exp Brain Res; 2024 Apr; 242(4):971-986. PubMed ID: 38430248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking.
    Stojkovska I; Wani WY; Zunke F; Belur NR; Pavlenko EA; Mwenda N; Sharma K; Francelle L; Mazzulli JR
    Neuron; 2022 Feb; 110(3):436-451.e11. PubMed ID: 34793693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy.
    Ganguly U; Chakrabarti SS; Kaur U; Mukherjee A; Chakrabarti S
    Curr Neuropharmacol; 2018; 16(7):1086-1097. PubMed ID: 29189163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological Correlates of Cognitive Decline in Parkinson's Disease: From Molecules to Neural Networks.
    Novikov NI; Brazhnik ES; Kitchigina VF
    Biochemistry (Mosc); 2023 Nov; 88(11):1890-1904. PubMed ID: 38105206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lippia grata essential oil complexed with β-cyclodextrin ameliorates biochemical and behavioral deficits in an animal model of progressive parkinsonism.
    Beserra-Filho JIA; Maria-Macêdo A; Silva-Martins S; Custódio-Silva AC; Soares-Silva B; Silva SP; Lambertucci RH; de Souza Araújo AA; Lucchese AM; Quintans-Júnior LJ; Santos JR; Silva RH; Ribeiro AM
    Metab Brain Dis; 2022 Oct; 37(7):2331-2347. PubMed ID: 35779151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nigrostriatal neuronal death following chronic dichlorvos exposure: crosstalk between mitochondrial impairments, α synuclein aggregation, oxidative damage and behavioral changes.
    Binukumar BK; Bal A; Kandimalla RJ; Gill KD
    Mol Brain; 2010 Nov; 3():35. PubMed ID: 21073741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.